Kathy Giacomini, PhD, who trained as a pharmacist and went on to become one of the foremost experts on pharmacogenomics with a focus on drug transporters, has been appointed dean of the UCSF School of Pharmacy.
UCSF is launching a new initiative to propel the development of living therapeutics – a category of treatments broadly defined as human and microbial living cells that are selected, modified, or engineered to treat or cure disease – and bring them quickly to patients.
Vice President Joe Biden and his wife Jill Biden visited UCSF to meet with top cancer experts as part of the National Cancer Moonshot initiative to develop new approaches that fast-forward the development of novel therapies.
Health and Human Services Secretary Sylvia Mathews Burwell said precision medicine will help researchers and doctors develop better, targeted medicine during her visit to UCSF’s Mission Bay campus Thursday.
Dan Lowenstein's distinguished career encompasses teaching, research and patient care – from his arrival to UCSF in 1987 as a pediatrics intern to his latest appointment as executive vice chancellor and provost.
Chancellor Susan Desmond-Hellman kicked off a special day-long symposium recognizing the winners of the 2014 Breakthrough Prizes in Life Sciences on Dec. 13. It was the centerpiece of a two-day celebration hosted by UCSF.